-
Sector Analysis
Israel General Insurance Market Size, Trends by Line of Business (Personal and Health, Financial Lines, Property, Motor, Marine, Aviation and Transit Insurance, and Miscellaneous), Distribution Channel, Competitive Landscape and Forecast, 2021-2025
The gross written premium of the Israel general insurance industry was ILS38.6 billion ($11.4 billion) in 2021. The market is expected to achieve a CAGR of more than 4% during 2020-2025. The Israel general insurance industry research report provides in-depth market analysis, information, insights, and a detailed outlook by product category for the Israeli general insurance segment. It also provides values for key performance indicators such as gross written premium, loss ratio, retail and commercial split, premium by line of...
-
Sector Analysis
Israel Life Insurance Market Size, Trends by Line of Business (Term, Endowment, Life PA&H and Others), Distribution Channel, Competitive Landscape and Forecast, 2021-2025
The gross written premium of the Israel life insurance industry was ILS41.5 billion ($12.2 billion) in 2021. The market is expected to achieve a CAGR of more than 3% during 2020-2025. The Israel life insurance industry research report provides in-depth market analysis, information, insights, and a detailed outlook by product category for the Israeli life insurance segment. It also provides values for key performance indicators such as gross written premium, paid claims, insurance penetration, and premium by line of business...
-
Sector Analysis
Strategic Market Intelligence: General Insurance in Israel – 2017
GlobalData’s 'Strategic Market Intelligence: General Insurance in Israel – 2017’ report provides in-depth market analysis, information and insights into the Israeli general insurance segment.
-
Track & Monitor
PharmSource – M&A in the Contract Manufacturing Industry: Implications and Outlook – 2018 Edition
This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.